WHO ICTRP trial
Efficacy and safety of portal vein stenting in combination with continuous…
ChiCTR2000033585 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000033585 |
|---|---|
| Public title | Efficacy and safety of portal vein stenting in combination with continuous chemotherapy infusion by hepatic artery and portal vein for patients with hepatocelluar carcinoma with main portal vein tumor thrombus |
| Scientific title | Efficacy and safety of portal vein stenting in combination with continuous chemotherapy infusion by hepatic artery and portal vein for patients with hepatocelluar carcinoma with main portal vein tumor thrombus |
| Primary sponsor | Fujian Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Primary hepatocellualr carcinoma |
| Interventions | experimental group:continous portal vein infusion chemotherapy |
| Registration date | Jun 6, 2020 |
| Target size | experimental group:36 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: